" /> Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine - CISMeF





Preferred Label : Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine;

NCIt synonyms : HER-2 pulsed DC vaccine; autologous dendritic cell/adenovirus HER-2 vaccine; Autologous Dendritic Cell-Adenovirus HER2 Vaccine; AdHer2/DC; Adenovirus-transduced HER-2 Autologous Dendritic Cell Vaccine;

NCIt definition : A cell-based cancer vaccine composed of autologous dendritic cells (DCs) transduced with a replication-deficient adenovirus vector encoding HER-2 with potential antineoplastic activity. Upon administration, adenovirus HER2-transduced autologous dendritic cell vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against HER-2-positive tumor cells, which may result in tumor cell death and decreased tumor growth. HER-2, a tyrosine kinase receptor for epidermal growth factor (EGF) (also known as neu and ErbB2), is overexpressed by some breast, ovarian, and gastric cancers.;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.